Comments

Kura Oncology Stock Guidance

KURANASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$7.94
0.232.98%
Q4 2024 Earnings were released on Wed Feb 26th, after the market close
The most recent conference call was at 16:30 PM, 5 days ago Click to view past webcast
Kura Oncology (KURA) ForecastNewsEarningsKura Oncology (KURA) Options

Guidance

DividendsAnalyst RatingsInsider TradesGovernment TradesShort Interest

Kura Oncology Stock Guidance | NASDAQ:KURA | Benzinga

Kura Oncology issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Kura Oncology (KURA)?

A

There have been no specific sales or earnings guidance reported for Kura Oncology in recent months.

Browse guidance and forecast on all stocks.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved